GuideAI Health Corp. has appointed Dr. James F. Benenati, a leading interventional radiologist, to its Advisory Board following FDA 510(k) clearance of its AI software, VascularAssist Occlusion Triage (VAOT). VAOT is designed to help radiologists prioritize and detect peripheral arterial disease earlier by flagging suspected vascular occlusions in routine CT scans, potentially speeding diagnosis and treatment. Dr. Benenati brings extensive clinical and research experience, enhancing GuideAI's mission to improve vascular disease detection and treatment precision. This move supports GuideAI's goal to advance its AI platform for better patient outcomes in vascular care.
Prestige Consumer Healthcare completed the acquisition of Australian therapeutic skin care company LaCorium Health for approximately $150 million in cash on July 1, 2026. LaCorium, known for brands like Dermal Therapy and Flexitol, generates about $4...
Diginex Limited has agreed with Resulticks to extend the deadline for their acquisition deal to July 31, 2026, after securing firm funding intent from private investors. The company does not plan to seek public funding and expects this to be the fina...
Rogers Communications has agreed to buy the remaining 25% stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports for C$4.35 billion, making Rogers the sole owner. This move aims to strengthen Rogers' position in Canadian sports and ente...
VERAXA Biotech updated on its progress in developing novel cancer therapies using its proprietary BiTAC platform, focusing on conditionally active T cell engagers and bispecific antibody-drug conjugates. The company plans to prioritize investment in ...
Taco Bell Canada introduced two new menu items: Crispy Chicken Nuggets with a Jalapeño Honey Mustard sauce, and Mountain Dew Baja Midnight, the first new Mountain Dew Baja Blast flavor in over 20 years. The nuggets feature all-white meat with Mexican...
